Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Continuous Glucose Monitoring System in Intensive Care Unit

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01995994
Recruitment Status : Completed
First Posted : November 27, 2013
Last Update Posted : May 21, 2015
Sponsor:
Information provided by (Responsible Party):
Jin-Tae Kim, Seoul National University Hospital

Brief Summary:
To assess the accuracy, safety, and influence of sampling site of Real-time continuous glucose monitoring system (Medtronic Guardian).

Condition or disease
Diabetic Blood Glucose Monitoring

Layout table for study information
Study Type : Observational
Actual Enrollment : 23 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Continuous Glucose Monitoring System in Intensive Care Unit - Preliminary Study Evaluating Accuracy
Study Start Date : June 2012
Actual Primary Completion Date : November 2013
Actual Study Completion Date : February 2014

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Blood Sugar

Group/Cohort
RT-CGM



Primary Outcome Measures :
  1. Difference between finger stick blood glucose and real-time continuous glucose monitoring [ Time Frame: 72 hours ]

Secondary Outcome Measures :
  1. Measurement error of real-time continuous glucose monitoring [ Time Frame: 72 hours ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients planned to stay in intensive care units longer than 72 hours
Criteria

Inclusion Criteria:

  • Older than 18 years old
  • Staying in intensive care units longer than 72 hours

Exclusion Criteria:

  • Skin disease
  • DIC
  • Immune suppressed patients

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01995994


Locations
Layout table for location information
Korea, Republic of
Seoul National University Hospital
Seoul, Korea, Republic of, 110-744
Sponsors and Collaborators
Seoul National University Hospital
Investigators
Layout table for investigator information
Principal Investigator: Jin-Tae Kim, MD. PhD. Seoul National University Hospital
Layout table for additonal information
Responsible Party: Jin-Tae Kim, Assistant Professor, Seoul National University Hospital
ClinicalTrials.gov Identifier: NCT01995994    
Other Study ID Numbers: D-1203-106-404
First Posted: November 27, 2013    Key Record Dates
Last Update Posted: May 21, 2015
Last Verified: November 2013